APCER Strengthens Global Scientific Expertise With Appointment of Dr Taku Seriu as Senior Adviser to its Board

Vinay Maurya

New Delhi, Delhi, India:  APCER, a leading global Pharmacovigilance services company that brings together safety, medical, regulatory and technology resources to ensure that patients receive the safest, most effective therapies possible, has announced the appointment of Dr Taku Seriu – a globally respected scientist and business leader in the pharmaceutical industry – as […]

RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs

Vinay Maurya

San Carlos, Calif., United States:   RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the use of RubrYc’s Meso-scale Engineered Molecules (MEMs) platform, to identify monoclonal antibodies with […]

Merck Foundation and African First Ladies Mark ‘World Health Day’ 2021 by Providing Scholarships for Doctors in New Specialities in Africa and Asia

Vinay Maurya

Windhoek, Namibia & Mumbai, Maharashtra, India:   Merck Foundation, year to date, in partnership with African First Ladies and Ministers of Health, have provided for more than 1100 doctors from 42 Countries with 1 & 2 year speciality scholarship to improve access to quality and equitable healthcare in Africa, Asia, […]

GLIDE Launches Inaugural Awards for Disease Elimination

Vinay Maurya

Abu Dhabi, United Arab Emirates & London, United Kingdom:   – New Abu Dhabi-based global health Institute launches its first disease elimination awards – 5 awards of up to USD200,000 each  The Global Institute for Disease Elimination (GLIDE), a new Abu Dhabi-based global health Institute focused on eliminating infectious diseases […]

LintonPharm Announces Authorization from China Health Authority (NMPA) to Proceed with a Phase 1/2 Trial Evaluating Catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer

Vinay Maurya

Guangzhou, China:   LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for cancer immunotherapy, today announced that China’s health authority, National Medical Products Administration (NMPA) authorized the company to proceed with a Phase 1/2 clinical trial (clinicaltrials.gov: NCT04799847) evaluating […]

Subscribe Now